SB656933
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
GlaxoSmithKline
Overview
SB656933 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SB656933 clinical trials
Explore related
Medical disclaimer. This page summarizes research about SB656933 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.